Resources
346 Results (showing 61 - 70)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 12/9/2020 (updated 4/3/2024)
Detailed risk benefit assessment of medications, settings and patient outcomes. These guidelines were developed in response to a resolution from the United Nations Economic and Social Council (ECOSOC), “to develop and publish minimum requirements and international guidelines on psychosocially assisted pharmacological treatment of persons dependent on opioids”
Posted 12/9/2020 (updated 4/3/2024)
State policymakers are interested in learning about the most effective treatments to address OUD and avoid unintended consequences such as overdose events, mortality from overdose, and use of illicit and unregulated drugs. This article describes the lack of evidence surrounding the use of Medically Supervised Withdrawal as a standalone “treatment.”
Posted 12/9/2020 (updated 4/3/2024)
Detoxification is the process of taking a person off an opioid on which he or she is physically dependent. The detoxification process can be fast or slow. This article describes the advantages and disadvantages of medically supervised withdrawal programs.
Posted 12/2/2020 (updated 4/3/2024)
Developed for the Puerto Rico Department of Health, this toolkit discusses how to screen pregnant women for substance use, screen infants for prenatal exposure to substances, recognize the signs of NAS, utilize validated screening tools, understand the importance of provider education, and engage pregnant women in the process of treatment and referral.
Posted 12/2/2020 (updated 4/3/2024)
This Association of Maternal & Child Health Programs (AMCHP) issue brief discusses the challenges and opportunities in providing rural community care to women with mental health and substance use treatment needs.
Posted 11/11/2020 (updated 4/3/2024)
West Virginia leads the nation in overdose death rate and both counties where participants were interviewed for this study were considered to be at risk for an HIV outbreak among people who inject drugs. This study asked the question ‘What on-the-ground environmental factors among PWIH could be contributing to this overdose rate?
Posted 11/11/2020 (updated 4/3/2024)
This report describes decedent demographic characteristics and circumstances surrounding overdose deaths during January–June 2019 among 25 jurisdictions participating in CDC’s State Unintentional Drug Overdose Reporting System (SUDORS),† and it highlights the involvement of opioids and stimulants, separately and in combination.
Posted 11/10/2020 (updated 4/3/2024)
In the context of the trends in Oregon SUD metrics and the increasing infectious complications related to IDU in other jurisdictions and their implications for HIV and HCV transmission, we sought to 1) describe statewide trends in IDU-related serious bacterial infections (SBI) hospitalizations overall and by SBI type and drug use diagnosis, 2) assess IDU-related SBI diagnoses among individuals living with HIV and HCV, and 3) and determine the annual costs of IDU-related SBI overall and by SBI type.
Posted 11/4/2020 (updated 4/3/2024)
The updated 2020 National Rural Health Day "Key Messages & Data Points" ePublication is full of rural-relevant data points that relate to the 3 NRHD key messages.
Posted 11/4/2020 (updated 4/3/2024)
The Council of State and Territorial Epidemiologists established the PMP Subcommittee to provide a platform for information exchange and addressing the need for a standardized metrics for opioid surveillance using PMP data. PMP group members identified a need to provide guidance for new PMP data users. Group members collaborated to write and develop a very comprehensive two-part How To Guide that provides instructions for new PMP data users.